HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein

Contact Levi & Korsinsky by January 17, 2025 Deadline to Join Class Action Against Humacyte, Inc.(HUMA)

Humacyte (NASDAQ:HUMA) Receives Buy Rating from D. Boral Capital

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

Class Action Filed Against Humacyte, Inc. (HUMA) - January 17, 2025 Deadline to Join - Contact The Gross Law Firm

HUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit